1. Home
  2. SWRD vs PHAT Comparison

SWRD vs PHAT Comparison

Compare SWRD & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stewards Inc Common Stock

SWRD

Stewards Inc Common Stock

N/A

Current Price

$3.14

Market Cap

593.4M

Sector

Finance

ML Signal

N/A

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

N/A

Current Price

$5.85

Market Cap

590.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWRD
PHAT
Founded
1999
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
593.4M
590.6M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
SWRD
PHAT
Price
$3.14
$5.85
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $20.05
AVG Volume (30 Days)
238.9K
★ 1.7M
Earning Date
11-17-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 42.72
EPS
★ N/A
N/A
Revenue
N/A
★ $175,110,000.00
Revenue This Year
N/A
$79.63
Revenue Next Year
N/A
$54.71
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 216.93
52 Week Low
$1.79
$5.02
52 Week High
$3.57
$18.31

Technical Indicators

Market Signals
Indicator
SWRD
PHAT
Relative Strength Index (RSI) 61.73 34.30
Support Level $2.26 $5.02
Resistance Level $3.57 $7.72
Average True Range (ATR) 0.35 0.62
MACD 0.05 -0.06
Stochastic Oscillator 68.16 28.10

Price Performance

Historical Comparison
SWRD
PHAT

About SWRD Stewards Inc Common Stock

Stewards Inc is a diversified financial services company with two complementary business platforms: Private Credit and Real Estate. It provides alternative financing solutions to small and medium-sized businesses (SMBs) underserved by traditional lenders, while also building a portfolio of income-producing and value enhancing real estate assets. The Private Credit Division provides revenue-based funding and related financing products to SMBs nationwide. The Real Estate Division targets strategic investments in residential, mixed-use, and commercial properties designed to generate stable rental income and have the potential for long-term value appreciation. It operates in two segments Financing Solutions, and Real Estate Operations.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: